Multifocality in retroperitoneal sarcoma: A prognostic factor critical to surgical decision-making

Annals of Surgery

Volumn 249, Issue 1, 2009, Pages 137-142

  Anaya, Daniel A ^a   Lahat, Guy ^a   Liu, Jun ^a   Xing, Yan ^a   Cormier, Janice N ^a   Pisters, Peter W ^a   Lev, Dina C ^a   Pollock, Raphael E ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL DECISION MAKING; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; RETROPERITONEAL SARCOMA; RETROSPECTIVE STUDY; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROPERITONEAL TUMOR; SARCOMA; SURVIVAL RATE;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; SARCOMA; SURVIVAL RATE;

EID: 58749101919     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181928f2f     Document Type: Article

References (30)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
2. Kotilingam D, Lev DC, Lazar AJ, et al. Staging soft tissue sarcoma: evolution and change. CA Cancer J Clin. 2006;56:282-291; quiz 314-315.
3. Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population- based analysis of epidemiology, surgery, and radiotherapy. Cancer. 2006; 106:1610-1616.
4. Jaques DP, Coit DG, Hajdu SI, et al. Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg. 1990;212:51-59.
5. Mendenhall WM, Zlotecki RA, Hochwald SN, et al. Retroperitoneal soft tissue sarcoma. Cancer. 2005;104:669-675.
6. Raut CP, Pisters PW. Retroperitoneal sarcomas: combined-modality treatment approaches. J Surg Oncol. 2006;94:81-87.
7. Ballo MT, Zagars GK, Pollock RE, et al. Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007;67:158-163.
8. Katz MH, Choi EA, Pollock RE. Current concepts in multimodality therapy for retroperitoneal sarcoma. Expert Rev Anticancer Ther. 2007;7:159-168.
9. Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228:355-365.
10. Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperito- neal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92:359-368.
11. Hassan I, Park SZ, Donohue JH, et al. Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience. Ann Surg. 2004;239:244-250.
12. Gronchi A, Casali PG, Fiore M, et al. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer. 2004;100:2448-2455.
13. Catton CN, O'Sullivan B, Kotwall C, et al. Outcome and prognosis in retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 1994;29: 1005-1010.
14. Ruka W, Emrich LJ, Driscoll DL, et al. Clinical factors and treatment parameters affecting prognosis in adult high-grade soft tissue sarcomas: a retrospective review of 267 cases. Eur J Surg Oncol. 1989;15:411-423.
15. Blair SL, Lewis JJ, Leung D, et al. Multifocal extremity sarcoma: an uncommon and controversial entity. Ann Surg Oncol. 1998;5:37-40.
16. Evans HL. Liposarcoma: a study of 55 cases with a reassessment of its classi?cation. Am J Surg Pathol. 1979;3:507-523.
17. Evans HL. Atypical lipomatous tumor, its variants, and its combined forms: a study of 61 cases, with a minimum follow-up of 10 years. Am J Surg Pathol. 2007;31:1-14.
18. Lahat G, Anaya DA, Wang X, et al. Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches. Ann Surg Oncol. 2008;15:1585-1593.
19. Singer S, Antonescu CR, Riedel E, et al. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal lipo- sarcoma. Ann Surg. 2003;238:358-370; discussion 370-371.
20. Van Dalen T, Hoekstra HJ, van Geel AN, et al. Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients. Eur J Surg Oncol. 2001;27:564-568.
21. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002.
22. Brennan MF. Staging of soft tissue sarcomas. Ann Surg Oncol. 1999;6: 8-9.
23. Bilimoria MM, Holtz DJ, Mirza NQ, et al. Tumor volume as a prognostic factor for sarcomatosis. Cancer. 2002;94:2441-2446.
24. Glehen O, Gilly FN. Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma. Surg Oncol Clin N Am. 2003;12:649-671.
25. Bauer TW, Hahn SM, Spitz FR, et al. Preliminary report of photodynamic therapy for intraperitoneal sarcomatosis. Ann Surg Oncol. 2001;8:254- 259.
26. Rossi CR, Deraco M, De Simone M, et al. Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients. Cancer. 2004;100:1943-1950.
27. Bonvalot S, Cavalcanti A, Le Pechoux C, et al. Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytore- duction alone in patients with peritoneal sarcomatosis. Eur J Surg Oncol. 2005;31:917-923.
28. Lim SJ, Cormier JN, Feig BW, et al. Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis. Ann Surg Oncol. 2007;14:2309-2318.
29. Marano I, Donnianni T, Di Lorenzo P, et al. Computerized tomography and magnetic resonance in the study of retroperitoneal sarcomas. Radiol Med (Torino). 1998;96:232-237.
30. Francis IR, Cohan RH, Varma DG, et al. Retroperitoneal sarcomas. Cancer Imaging. 2005;5:89-94